01-05-1998 | Clinical Pharmacoeconomic
Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia
Clinical and Economic Outcomes
Published in: Clinical Drug Investigation | Issue 5/1998
Login to get access